HK Stock MarketDetailed Quotes

3D MEDICINES (01244)

Watchlist
  • 3.820
  • +0.100+2.69%
Market Closed Apr 30 16:00 CST
986.24MMarket Cap-5.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

3D MEDICINES (01244) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
-20.10%356.09M
1.33%209.17M
-29.81%445.65M
-41.45%206.42M
11.91%634.95M
--352.55M
841.57%567.39M
--60.26M
----
----
Operating income
-20.10%356.09M
1.33%209.17M
-29.81%445.65M
-41.45%206.42M
11.91%634.95M
352.55M
841.57%567.39M
60.26M
Cost of sales
22.95%-28.18M
6.94%-16.26M
25.50%-36.57M
36.00%-17.47M
-16.29%-49.09M
---27.3M
-887.02%-42.22M
---4.28M
----
----
Operating expenses
22.95%-28.18M
6.94%-16.26M
25.50%-36.57M
36.00%-17.47M
-16.29%-49.09M
-27.3M
-887.02%-42.22M
-4.28M
Gross profit
-19.84%327.91M
2.09%192.91M
-30.18%409.08M
-41.91%188.95M
11.55%585.86M
325.25M
838.10%525.18M
55.98M
Selling expenses
21.48%-185.25M
-1.33%-111.55M
37.72%-235.94M
50.18%-110.08M
-5.91%-378.81M
---220.97M
-734.99%-357.66M
---42.83M
----
----
Administrative expenses
9.99%-70.44M
31.65%-29.74M
63.95%-78.26M
44.49%-43.5M
-51.98%-217.08M
---78.37M
5.38%-142.83M
-272.47%-150.96M
1.37%-40.53M
---41.09M
Research and development expenses
13.62%-156.1M
2.54%-83.12M
57.53%-180.72M
43.74%-85.29M
-21.27%-425.5M
---151.61M
5.47%-350.86M
-40.61%-371.16M
-15.07%-263.97M
---229.39M
Revaluation surplus
----
----
----
----
----
----
31.17%-657.16M
-199.07%-954.74M
-23,830.43%-319.23M
---1.33M
-Changes in the fair value of other assets
----
----
----
----
----
----
31.17%-657.16M
-199.07%-954.74M
-23,830.43%-319.23M
---1.33M
Impairment and provision
54.13%-4.61M
39.15%-2.9M
-1,301.55%-10.06M
-1,622.38%-4.77M
171.23%837K
---277K
-803.85%-1.18M
---130K
----
----
-Other impairment is provision
54.13%-4.61M
39.15%-2.9M
-1,301.55%-10.06M
-1,622.38%-4.77M
171.23%837K
---277K
-803.85%-1.18M
---130K
----
----
Special items of operating profit
2.93%-91.23M
-1.24%-54.99M
21.69%-93.98M
9.77%-54.32M
-86.31%-120.01M
---60.19M
-1,917.47%-64.41M
198.66%3.54M
89.25%-3.59M
---33.41M
Operating profit
5.35%-179.71M
18.00%-89.39M
65.77%-189.88M
41.44%-109.01M
47.12%-554.69M
-186.16M
28.17%-1.05B
-132.78%-1.46B
-105.53%-627.32M
-305.23M
Financing cost
44.98%-5.23M
34.76%-3.3M
-22.27%-9.5M
-25.23%-5.06M
-149.66%-7.77M
---4.04M
-103.73%-3.11M
81.04%-1.53M
47.01%-8.06M
---15.21M
Earning before tax
7.24%-184.94M
18.75%-92.69M
64.55%-199.38M
40.03%-114.07M
46.54%-562.47M
-190.2M
28.03%-1.05B
-130.07%-1.46B
-98.29%-635.38M
-320.43M
Tax
--55K
--55K
----
----
---55K
----
----
----
----
----
After-tax profit from continuing operations
7.27%-184.89M
18.79%-92.63M
64.56%-199.38M
40.03%-114.07M
46.53%-562.52M
-190.2M
28.03%-1.05B
-130.07%-1.46B
-98.29%-635.38M
-320.43M
Earning after tax
7.27%-184.89M
18.79%-92.63M
64.56%-199.38M
40.03%-114.07M
46.53%-562.52M
-190.2M
28.03%-1.05B
-130.07%-1.46B
-98.29%-635.38M
-320.43M
Minority profit
55.99%-7.36M
68.92%-3.28M
55.81%-16.72M
9.85%-10.57M
-36.65%-37.82M
---11.72M
0.19%-27.68M
---27.73M
----
----
Profit attributable to shareholders
2.81%-177.53M
13.68%-89.35M
65.19%-182.66M
42.01%-103.51M
48.78%-524.7M
-178.49M
28.57%-1.02B
-125.71%-1.43B
-98.29%-635.38M
-320.43M
Basic earnings per share
4.00%-0.72
14.29%-0.36
67.39%-0.75
46.84%-0.42
89.79%-2.3
-0.79
38.67%-22.52
-163.60%-36.72
-34.20%-13.93
-10.38
Diluted earnings per share
4.00%-0.72
14.29%-0.36
67.39%-0.75
46.84%-0.42
89.79%-2.3
-0.79
38.67%-22.52
-163.60%-36.72
-34.20%-13.93
-10.38
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
--
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
--
Modern Ancheng Certified Public Accountants Co., Ltd.
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
Ernst & Young
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover -20.10%356.09M1.33%209.17M-29.81%445.65M-41.45%206.42M11.91%634.95M--352.55M841.57%567.39M--60.26M--------
Operating income -20.10%356.09M1.33%209.17M-29.81%445.65M-41.45%206.42M11.91%634.95M352.55M841.57%567.39M60.26M
Cost of sales 22.95%-28.18M6.94%-16.26M25.50%-36.57M36.00%-17.47M-16.29%-49.09M---27.3M-887.02%-42.22M---4.28M--------
Operating expenses 22.95%-28.18M6.94%-16.26M25.50%-36.57M36.00%-17.47M-16.29%-49.09M-27.3M-887.02%-42.22M-4.28M
Gross profit -19.84%327.91M2.09%192.91M-30.18%409.08M-41.91%188.95M11.55%585.86M325.25M838.10%525.18M55.98M
Selling expenses 21.48%-185.25M-1.33%-111.55M37.72%-235.94M50.18%-110.08M-5.91%-378.81M---220.97M-734.99%-357.66M---42.83M--------
Administrative expenses 9.99%-70.44M31.65%-29.74M63.95%-78.26M44.49%-43.5M-51.98%-217.08M---78.37M5.38%-142.83M-272.47%-150.96M1.37%-40.53M---41.09M
Research and development expenses 13.62%-156.1M2.54%-83.12M57.53%-180.72M43.74%-85.29M-21.27%-425.5M---151.61M5.47%-350.86M-40.61%-371.16M-15.07%-263.97M---229.39M
Revaluation surplus ------------------------31.17%-657.16M-199.07%-954.74M-23,830.43%-319.23M---1.33M
-Changes in the fair value of other assets ------------------------31.17%-657.16M-199.07%-954.74M-23,830.43%-319.23M---1.33M
Impairment and provision 54.13%-4.61M39.15%-2.9M-1,301.55%-10.06M-1,622.38%-4.77M171.23%837K---277K-803.85%-1.18M---130K--------
-Other impairment is provision 54.13%-4.61M39.15%-2.9M-1,301.55%-10.06M-1,622.38%-4.77M171.23%837K---277K-803.85%-1.18M---130K--------
Special items of operating profit 2.93%-91.23M-1.24%-54.99M21.69%-93.98M9.77%-54.32M-86.31%-120.01M---60.19M-1,917.47%-64.41M198.66%3.54M89.25%-3.59M---33.41M
Operating profit 5.35%-179.71M18.00%-89.39M65.77%-189.88M41.44%-109.01M47.12%-554.69M-186.16M28.17%-1.05B-132.78%-1.46B-105.53%-627.32M-305.23M
Financing cost 44.98%-5.23M34.76%-3.3M-22.27%-9.5M-25.23%-5.06M-149.66%-7.77M---4.04M-103.73%-3.11M81.04%-1.53M47.01%-8.06M---15.21M
Earning before tax 7.24%-184.94M18.75%-92.69M64.55%-199.38M40.03%-114.07M46.54%-562.47M-190.2M28.03%-1.05B-130.07%-1.46B-98.29%-635.38M-320.43M
Tax --55K--55K-----------55K--------------------
After-tax profit from continuing operations 7.27%-184.89M18.79%-92.63M64.56%-199.38M40.03%-114.07M46.53%-562.52M-190.2M28.03%-1.05B-130.07%-1.46B-98.29%-635.38M-320.43M
Earning after tax 7.27%-184.89M18.79%-92.63M64.56%-199.38M40.03%-114.07M46.53%-562.52M-190.2M28.03%-1.05B-130.07%-1.46B-98.29%-635.38M-320.43M
Minority profit 55.99%-7.36M68.92%-3.28M55.81%-16.72M9.85%-10.57M-36.65%-37.82M---11.72M0.19%-27.68M---27.73M--------
Profit attributable to shareholders 2.81%-177.53M13.68%-89.35M65.19%-182.66M42.01%-103.51M48.78%-524.7M-178.49M28.57%-1.02B-125.71%-1.43B-98.29%-635.38M-320.43M
Basic earnings per share 4.00%-0.7214.29%-0.3667.39%-0.7546.84%-0.4289.79%-2.3-0.7938.67%-22.52-163.60%-36.72-34.20%-13.93-10.38
Diluted earnings per share 4.00%-0.7214.29%-0.3667.39%-0.7546.84%-0.4289.79%-2.3-0.7938.67%-22.52-163.60%-36.72-34.20%-13.93-10.38
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --------Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor ----Modern Ancheng Certified Public Accountants Co., Ltd.--Ernst & Young--Ernst & YoungErnst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -